L. Pelttari

发表

RAD51B in Familial Breast Cancer

S. Cross, M. Beckmann, P. Fasching, 2016, PloS one.

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Yurii B. Shvetsov, A. Whittemore, L. Kiemeney, 2015, PloS one.

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Sebastian M. Armasu, Yurii B. Shvetsov, A. Whittemore, 2013, Nature Communications.

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Yurii B. Shvetsov, Simon G. Coetzee, A. Whittemore, 2015, Nature Genetics.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Lara E Sucheston-Campbell, Simon G. Coetzee, Lara E. Sucheston-Campbell, 2017, Nature Genetics.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31

Sebastian M. Armasu, Yurii B. Shvetsov, A. Whittemore, 2013 .

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

A. Whittemore, L. Kiemeney, M. Pike, 2013, Nature Communications.

Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia

M. Irving, J. Koskenvuo, L. Pelttari, 2021, Orphanet Journal of Rare Diseases.

Genetics of Breast and Ovarian Cancer Predisposition with a Focus on RAD51C and RAD51D Genes

L. Pelttari, Liisa M. Pelttari, 2018 .

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

David N. Rider, A. Whittemore, L. Kiemeney, 2014, Cancer research.

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

F. Couch, Sofia Khan, J. Schleutker, 2014, Proceedings of the National Academy of Sciences.

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

J. Schleutker, H. Nevanlinna, A. Kallioniemi, 2019, International journal of cancer.

HOXB 13 G 84 E Mutation in Finland : Population-Based Analysis of Prostate , Breast , and Colorectal Cancer Risk

L. Aaltonen, J. Schleutker, Tiina Wahlfors, 2013 .

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

Julie O. Culver, F. Couch, S. Gruber, 2020, Journal of the National Cancer Institute.

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, A. Whittemore, 2013, Human Genetics.

Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer

Pejovic, Dicks, Hein, 2015 .

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

Dong Liang, Thilo Dörk, Natalia Bogdanova, 2014, Molecular nutrition & food research.

Screening of Finnish RAD 51 C founder mutations in prostate and colorectal cancer patients

L. Aaltonen, J. Schleutker, H. Nevanlinna, 2022 .

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

Brigitte Rack, Seth Slettedahl, Heli Nevanlinna, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

randomization Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

A. Whittemore, M. Beckmann, A. Hein, 2016 .

AD51B in Familial Breast Cancer

Claude, Janet, Fergus, 2016 .

Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

Yurii B. Shvetsov, Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, 2015, Genetic epidemiology.

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome

Sofia Khan, H. Nevanlinna, R. Fagerholm, 2016, International journal of cancer.

Variants on the promoter region of PTEN affect breast cancer progression and patient survival

Päivi Heikkilä, Dario Greco, Heli Nevanlinna, 2011, Breast Cancer Research.

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

H. Nevanlinna, K. Aittomäki, C. Blomqvist, 2017, BMC Cancer.

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Sofia Khan, J. Schleutker, Å. Borg, 2017, Breast Cancer Research and Treatment.

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Sofia Khan, D. Easton, H. Nevanlinna, 2016, Breast Cancer Research and Treatment.

Screening of HELQ in breast and ovarian cancer families

Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, 2015, Familial Cancer.

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

H. Nevanlinna, K. Aittomäki, C. Blomqvist, 2015, SpringerPlus.

HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

L. Aaltonen, J. Schleutker, Tiina Wahlfors, 2013, Cancer Epidemiology, Biomarkers & Prevention.

RAD 51 , XRCC 3 , and XRCC 2 mutation screening in Finnish breast cancer families

H. Nevanlinna, K. Aittomäki, C. Blomqvist, 2022 .

RAD51C is a susceptibility gene for ovarian cancer.

J. Schleutker, H. Nevanlinna, A. Kallioniemi, 2011, Human molecular genetics.

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients

L. Aaltonen, J. Schleutker, H. Nevanlinna, 2012, BMC Cancer.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Genome-wide significant risk associations for mucinous ovarian carcinoma

Yurii B. Shvetsov, A. Whittemore, L. Kiemeney, 2015, Nature Genetics.

Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.

A. Whittemore, A. Morris, L. Kiemeney, 2015, Human molecular genetics.

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

Yurii B. Shvetsov, A. Whittemore, L. Kiemeney, 2016, Oncotarget.

Common variants at the CHEK 2 gene locus and risk of epithelial ovarian cancer

Pejovic, Dicks, Hein, 2015 .

Gene‐panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication

F. Couch, Å. Borg, H. Nevanlinna, 2018, Clinical genetics.

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

L. Aaltonen, J. Schleutker, H. Nevanlinna, 2012, Journal of Medical Genetics.

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

Yurii B. Shvetsov, A. Whittemore, L. Kiemeney, 2018, British Journal of Cancer.

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

A. Whittemore, L. Kiemeney, M. Beckmann, 2016, Human Genetics.

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

L. Aaltonen, O. Abdel-Wahab, H. Nevanlinna, 2012, British Journal of Cancer.

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

Dong Liang, Brooke L. Fridley, Jennifer A. Doherty, 2015, Journal of genetics and genome research.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

Dong Liang, Brooke L. Fridley, Jennifer A. Doherty, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Lara E Sucheston-Campbell, Simon G. Coetzee, Dennis J. Hazelett, 2017, Nature Genetics.

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Brooke L. Fridley, Matthias W. Beckmann, Peter A. Fasching, 2013, Nature Genetics.

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

Yurii B. Shvetsov, Lara E Sucheston-Campbell, A. Whittemore, 2015, Gynecologic oncology.

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

A. Whittemore, L. Kiemeney, M. Beckmann, 2016, International journal of epidemiology.

Mendelian randomization Association of vitamin D levels and risk of ovarian cancer : a Mendelian randomization study

A. Whittemore, L. Kiemeney, M. Beckmann, 2016 .

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

Yurii B. Shvetsov, Lara E Sucheston-Campbell, A. Whittemore, 2018, PloS one.

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Yurii B. Shvetsov, Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, 2016, Oncotarget.

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.

A. Whittemore, L. Kiemeney, M. Pike, 2016, International journal of epidemiology.

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

A. Whittemore, L. Kiemeney, M. Pike, 2015, Nature Communications.

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

Yurii B. Shvetsov, A. Whittemore, L. Kiemeney, 2018, International journal of molecular sciences.

New VOUS in CASK Gene Correlating with the MICPCH Phenotype.

L. Pelttari, A. Mirea, M. Leanca, 2021, Maedica.